A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...
The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in the U.S. ages 8 to 17.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback